Skip to content

Getting the formula right to deliver HIV services, including ART, to TB patients with HIV

Plans to harmonise data collection and reporting of TB/HIV collaborative activities

Programmes gradually adopting TB/HIV activities, as funding and technical partners harmonise monitoring and evaluation

Programmes begin to nurture much needed TB/HIV advocacy

Antiretroviral use increases survival sixfold in Thai patients with HIV and tuberculosis

Opt-out testing increases HIV counselling and testing rates in South African TB clinics

Shorter TB treatment regimens would provide survival benefit in high HIV-prevalence regions: mathematical model

4 months of rifampicin safer than 9 months of isoniazid for TB prevention

Combining rifampicin with increased doses of lopinavir/ritonavir tablets leads to dangerous increases in liver enzymes